Press Releases

FDA Clears Apollo Endosurgery’s SuMO™ Endoscopic Tissue Access and Resection System | 1/4/2012
SuMO System Allows Physicians to Perform Scarless Surgery to Remove Large Flat Pre-Cancerous Lesions During Colonoscopies and Upper Endoscopies
Apollo Endosurgery® Signs Agreement with Apollo Hospitals Group to Advance Incisionless Bariatric Surgery in India | 9/29/2011
Apollo Endosurgery®, Inc. announced today that it has signed a Memorandum of Understanding (MOU) with Apollo Hospitals Group, one of the largest healthcare networks in Asia, to promote the adoption of incisionless bariatric procedures with flexible surgery tools in India
Apollo  Endosurgery® Announces First Incisionless Full-­thickness Resection of a Colonic Polyp  | 8/29/2011
OverStitch™ Endoscopic Suturing System Allowed Doctors to Close Large Wound in Colon Using Incisionless Approach without Laparoscopic Assistance
Apollo Endosurgery Taps Michael Doty for CFO | 6/7/2011
Apollo Endosurgery, Inc., a leading company in the emerging field of flexible surgery, announced today the appointment of Michael J. Doty as Chief Financial Officer (CFO).
New Class of Flexible Instruments from Apollo Endosurgery® Used for Endoluminal Removal of Gastric Tumor | 4/15/2011
Florida Hospital Celebration Health announced this week the use of a new class of flexible surgical instruments created by Apollo Endosurgery®, to remove a stomach tumor and extract it through the patient’s mouth.
Apollo Endosurgery Demonstrates Clinical Functionality of the Newly Launched OverStitch™ Endoscopic Suturing System in Bariatric Repairs and GI Therapy  | 1/11/2011
Apollo Endosurgery, Inc. announced preliminary results from their GEMINI suturing registry.  These results confirm the procedure enabling capability of their newly-launched OverStitch™ Endoscopic Suturing System in a variety of clinical cases in the esophagus, stomach and colon.
Apollo Endosurgery Completes First-in-Human Cases with New OverStitch™ Endoscopic Suturing System | 11/1/2010
Apollo Endosurgery, Inc. announced that their newlylaunched OverStitch™ Endoscopic Suturing System has recently been employed in several, first-in-human cases.
Apollo Endosurgery Completes First Clinical Case with Newly-Launched FlexShears™ Endoscopic Scissors | 10/7/2010
Apollo Endosurgery, Inc. announced completion of the first clinical case involving its FlexShears™ Endoscopic Scissors. The new device was used to cut and remove an obstructing eroded suture from the patient’s GI tract in a procedure that embodies the Apollo vision of improving patient care with flexible surgery.
Apollo Endosurgery recommended for $5 million Commercialization Award from the Cancer Prevention and Research Institute of Texas | 6/22/2010
Apollo Endosurgery announced today that the Company received notice of a $5 million award from the State of Texas through the Cancer Prevention and Research Institute of Texas (“CPRIT”). Apollo was one of only three companies recommended for the inaugural commercialization awards. CPRIT was established to expedite innovation and commercialization in the area of cancer research and to enhance access to evidence-based prevention programs and services throughout the State. Acceptance of the award is subject to the completion of final due diligence and contract negotiations.
Apollo Endosurgery Introduces New "Flexible Surgery" Products at SAGES 2010 | 5/7/2010
Apollo Endosurgery, Inc. has just concluded a successful participation at the 12th World Congress of Endoscopic Surgery, where they previewed two new products: The OverStitch™ Endoscopic Suturing System and the FlexShears™ Endoscopic Scissors.
Apollo Endosurgery Announces 510(k) Clearance for its Flexible Endoscopic Suturing System | 10/2/2008
Apollo Endosurgery Inc. announced today that the FDA has cleared a 510(k) application to market its OVERSTITCH™ endoscopic suture system. This allowance opens the way for US commercial release of the product which is anticipated for late 2008.
Apollo Endosurgery, Inc. secures $11.5 million in Series A Financing | 10/8/2007
Apollo Endosurgery, Inc., an early stage company developing medical devices for minimally invasive surgical procedures conducted through natural orifices, today announced it has secured $11.5 million in Series A financing from PTV Sciences, H.I.G. Ventures, and individual investors. Proceeds from this financing will be used to complete product development and conduct human clinical trials in the U.S.
UTMB Helps Launch Apollo Endosurgery | 8/20/2006
The University of Texas Medical Branch at Galveston (UTMB) has signed a technology licensing agreement with a new Austin, Texas, based medical device start-up company, Apollo Endosurgery.